Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,295,658 | Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof In force · High confidence UsedRemaining | Atossa Therapeutics, Inc. | In force | High confidence | ||
| Application 12/852,620 | Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof Abandoned Abandoned May 18, 2014 | Atossa Therapeutics, Inc. | Abandoned | Abandoned May 18, 2014 | ||
| Application 13/761,243 | Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof Abandoned Abandoned Jul 23, 2015 | Atossa Therapeutics, Inc. | Abandoned | Abandoned Jul 23, 2015 | ||
| Application 15/083,636 | Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof Abandoned Abandoned Nov 28, 2017 | Atossa Therapeutics, Inc. | Abandoned | Abandoned Nov 28, 2017 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Atossa Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.